Abiomed is recalling the Impella Intravascular Left Sided Blood Pumps because the pump’s Instructions for Use (IFU) do not adequately address precautions to take when treating patients who have undergone transcatheter aortic valve replacement (TAVR)
Abbott (NYSE: ABT) today announced two new clearances from the U.S. Food and Drug Administration (FDA) for the company's industry-leading life support system. With the new indication, the CentriMag Blood Pump for use with the CentriMag™ System, is now cleared for longer-term use in adults when extracorporeal .
Because of the impression of untapped market potential and regulatory barriers, the financial world pays insufficient attention to the heart disease sector or industry of blood pump technology made up of scientists, physicians, and businesses.Access the sample report: https://www.insightslice.com/request-sample/1247.